Department of Medical and Surgical Sciences, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy.
Atherosclerosis. 2012 Jan;220(1):201-7. doi: 10.1016/j.atherosclerosis.2011.09.023. Epub 2011 Sep 22.
To explore the independent and combined clinical validity of estimated glomerular filtration rate (eGFR) and proteinuria on predicting all-cause and cardiovascular mortality in an Italian elderly population.
Baseline eGFR and proteinuria, all-cause and cardiovascular mortality during a mean follow-up time of 4.4 years were evaluated in 3063 subjects aged 65 years and older of the Progetto Veneto Anziani (Pro.V.A.) Study.
Subjects with eGFR<60ml/min/1.73m(2) (n=956) presented a higher prevalence of proteinuria in comparison with those with eGFR≥60ml/min/1.73m(2) (33.8% vs 25.1%, p<0.01). After multivariable adjustment including proteinuria and major diseases, eGFR<60ml/min/1.73m(2) was not associated with increased all-cause mortality. After multivariable adjustment including eGFR and major diseases, proteinuria was associated with all-cause mortality in overall subjects (HR=1.43, 95% CI 1.15-1.78, p<0.01), and in both sexes. After multivariable adjustment both eGFR<60ml/min/1.73m(2) (HR=1.68, 95% CI 1.02-2.78, p=0.04), and proteinuria (HR=2.07, 95% CI 1.31-3.27, p<0.01) were associated with increased cardiovascular mortality. Subjects with both impaired eGFR and presence of proteinuria showed a higher risk for both all-cause and cardiovascular mortality compared to those with normal eGFR and absence of proteinuria.
In this general Italian elderly population proteinuria is an independent predictor of all-cause and cardiovascular mortality, while eGFR is not an independent predictor of all-cause mortality, and it is nominally significantly associated with cardiovascular mortality. However, mortality risk is higher in individuals with combined reduced eGFR and proteinuria.
探讨估算肾小球滤过率(eGFR)和蛋白尿在预测意大利老年人群全因和心血管死亡率方面的独立和联合临床有效性。
在 Progetto Veneto Anziani(Pro.V.A.)研究中,评估了 3063 名年龄在 65 岁及以上的受试者的基线 eGFR 和蛋白尿、平均随访时间为 4.4 年期间的全因和心血管死亡率。
与 eGFR≥60ml/min/1.73m(2)的受试者相比,eGFR<60ml/min/1.73m(2)(n=956)的受试者蛋白尿的患病率更高(33.8% vs 25.1%,p<0.01)。在包括蛋白尿和主要疾病在内的多变量调整后,eGFR<60ml/min/1.73m(2)与全因死亡率增加无关。在包括 eGFR 和主要疾病在内的多变量调整后,蛋白尿与所有受试者的全因死亡率相关(HR=1.43,95%CI 1.15-1.78,p<0.01),并且在男女两性中均如此。在多变量调整后,eGFR<60ml/min/1.73m(2)(HR=1.68,95%CI 1.02-2.78,p=0.04)和蛋白尿(HR=2.07,95%CI 1.31-3.27,p<0.01)与心血管死亡率增加相关。与 eGFR 正常且无蛋白尿的受试者相比,同时存在 eGFR 受损和蛋白尿的受试者的全因和心血管死亡率风险更高。
在这个普通的意大利老年人群中,蛋白尿是全因和心血管死亡率的独立预测因子,而 eGFR 不是全因死亡率的独立预测因子,与心血管死亡率有一定的显著关联。然而,在同时存在 eGFR 降低和蛋白尿的个体中,死亡率风险更高。